6254
Nomura Micro Science Co.,Ltd.
野村マイクロ・サイエンス株式会社Nomura Micro Science Co., Ltd. engages in the design, installation, and sale of water treatment technologies in Japan, South Korea, Taiwan, China, and the United States. The company offers water treatment plants and equipment, including pure and ultra-pure water systems, pharmaceutical water production systems, wastewater treatment systems, and water reclamation systems. It also provides pretreatment systems, heat regenerative type membrane filtration equipment, coagulating sedimentation equipment, flocculation filtration, gravity filtration, and pressure filtration equipment, electrodeionization, ion exchange systems, reverse osmosis (RO) systems, vacuum and membrane degasifier, pure steam generators, package type purified water production systems, WFI production systems, ozone and hydrogen water production systems, and anti-static equipment. In addition, the company offers return contamination monitor, H2O2 monitor, nuclepore membrane, filter cartridge, and piping and environmental materials; and site supply of pure water, and water analysis and evaluation services on a contract basis. It serves electronics, pharmaceutical, biotechnology, food, environment and energy, and analysis industries. Nomura Micro Science Co., Ltd. was incorporated in 1969 and is headquartered in Atsugi, Japan.
Price
¥4,590
Market Cap
¥173.8B
Ent. Value
¥208.6B
Net Debt
−¥34.8B
Shares Out.
37.9M
P / E
17.0×
EV / EBIT
13.6×
P / Book
4.76×
P / NCAV
5.95×
Div. Yield
1.74%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥96.4B | ¥73.0B | ¥49.6B | ¥31.9B |
| Cost of Sales | ¥75.2B | ¥57.6B | ¥39.2B | ¥24.2B |
| Gross Profit | ¥21.1B | ¥15.4B | ¥10.4B | ¥7.7B |
| SG&A | ¥5.7B | ¥4.8B | ¥3.8B | ¥3.2B |
| Operating Income | ¥15.4B | ¥10.6B | ¥6.6B | ¥4.4B |
| Non-Operating Income | ¥214M | ¥813M | ¥114M | ¥182M |
| Dividend Income | ¥28M | ¥19M | ¥17M | ¥16M |
| Interest Income | ¥45M | ¥82M | ¥29M | ¥19M |
| Non-Operating Expenses | ¥2.2B | ¥641M | ¥248M | ¥33M |
| Interest Expense | ¥1.9B | ¥589M | ¥57M | ¥31M |
| Ordinary Income | ¥13.4B | ¥10.8B | ¥6.4B | ¥4.6B |
| Pre-tax Income | ¥13.4B | ¥10.8B | ¥7.5B | ¥4.6B |
| Income Taxes | ¥3.2B | ¥2.8B | ¥1.6B | ¥1.3B |
| Current Tax | ¥4.0B | ¥2.7B | ¥1.7B | ¥1.3B |
| Deferred Tax | ¥-797M | ¥197M | ¥-17M | ¥-13M |
| Net Income (owners) | ¥10.2B | ¥8.0B | ¥5.8B | ¥3.3B |
| Comprehensive Income | ¥9.9B | ¥8.6B | ¥6.1B | ¥3.5B |
| EBITDA | ¥17.0B | ¥11.0B | ¥6.7B | ¥4.6B |
| EPS | ¥270.75 | ¥213.47 | ¥627.60 | ¥357.59 |
| Shares Outstanding | 37.9M | 9.4M | 9.3M | 9.2M |
| Shares Issued (total) | 40.6M | 10.2M | 10.2M | 10.2M |
| Treasury Shares | 2.7M | 0.8M | 0.8M | 0.9M |